Trade MerckCo USA ^MRK

Merck in License Pact Worth Up to $2.13 Billion With SciBrunch Therapeutics - Update | Morningstar

Merck (MRK) Secures Exclusive Rights to Cancer Drug in $2.13B SciBrunch Agreement

Merck, Daiichi end plans to seek speedy approval of lung cancer ADC

Merck Signs $2.13 Bln License Deal With SciBrunch Therapeutics For KRAS G12D Inhibitor

Merck in License Pact Worth Up to $2.13 Billion With SciBrunch Therapeutics | Morningstar

CAPVAXIVE® Included in Ontario's Publicly Funded Adult Pneumococcal Immunization Program | INN

Daiichi Sankyo, MSD withdraw cancer drug application

Promising Pharmaceutical Stocks To Consider - September 27th - Zolmax

Merck (MRK) Withdraws I-DXd Biologics License Application for ES

Merck, Daiichi Sankyo Withdraw Application for Accelerated Approval of Lung Cancer Treatment | Morningstar

J.P. Morgan Sticks to Their Buy Rating for Teva (TEVA)

Merck reveals study success, and possible safety worries, for eye drug hopeful

Merck sees pivotal victory for $3B eye disease prospect

Envestnet Portfolio Solutions Inc. Has $13.56 Million Stock Holdings in Merck & Co., Inc. $MRK

Envestnet Asset Management Inc. Has $513.60 Million Stock Holdings in Merck & Co., Inc. $MRK

DME red flag in Merck Brunello phase III? Surrozen finishes rich | BioWorld

QRG Capital Management Inc. Lowers Holdings in Merck & Co., Inc. $MRK

Healthcare Stocks To Add to Your Watchlist - September 23rd - Stock Observer

Merck & Co., Inc. (NYSE:MRK) Upgraded at Wall Street Zen - Zolmax

State Street Corp Has $15.57 Billion Position in Merck & Co., Inc. $MRK

Bladder Cancer Clinical Trial Pipeline: Emerging Therapies and Key Developments Shaping the Treatment Landscape | DelveInsight | ABNewswire

Merck's KEYTRUDA QLEX Approved In Japan For Subcutaneous Use

Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Envista Holdings (NVST) and Ultragenyx Pharmaceutical (RARE)

Merck & Co., Inc. (NYSE:MRK) Upgraded by Wall Street Zen to Buy Rating - Stock Observer

Merck & Co., Inc. (NYSE:MRK) Stock Rating Upgraded by Wall Street Zen

Promising Healthcare Stocks To Consider - September 19th - Markets Daily

Merck (MRK) Stock: Surge as HIV Health Campaign Launches at USCHA 2026

Nykredit A S Invests $92.32 Million in Merck & Co., Inc. $MRK

Top Pharmaceutical Stocks Worth Watching - September 17th - Markets Daily

Merck & Co. (MRK) is Building a Stronger Future Beyond Its Keytruda Franchise

Oncology Tie-Up and Blockchain Pilot Might Change The Case For Investing In Merck (MRK)

Merck & Co Inc's Dividend Analysis

RBC Capital Sticks to Their Buy Rating for AstraZeneca (AZN)

RBC Capital Sticks to Their Buy Rating for Roche Holding AG (RHHVF)

RBC Capital Sticks to Their Buy Rating for AbbVie (ABBV)

GlaxoSmithKline (GSK) Gets a Hold from RBC Capital

RBC Capital Sticks to Their Hold Rating for Merck & Company (MRK)

RBC Capital Sticks to Their Hold Rating for Bristol-Myers Squibb (BMY)

RBC Capital Keeps Their Hold Rating on Novartis AG (NOVN)

RBC Capital Sticks to Their Buy Rating for Eli Lilly & Co (LLY)

Congresswoman Bets on Elon Musk, Warren Buffett: Here's the Latest Stock Transactions

Top Pharmaceutical Stocks To Research - September 14th - Daily Political

Wall Street Zen Downgrades Merck & Co., Inc. (NYSE:MRK) to Hold - Stock Observer

Merck & Co., Inc. (MRK) to Issue Quarterly Dividend of $0.85 on October 7th - Zolmax

Pharmaceutical Stocks To Keep An Eye On - September 13th - Daily Political

Pharmaceutical Stocks To Follow Today - September 12th - Stock Observer

Merck & Co., Inc. (NYSE:MRK) Lowered to Hold Rating by Wall Street Zen

Merck & Co., Inc. (NYSE:MRK) Price Target Raised to $161.00 - Daily Political

7,741 Shares in Merck & Co., Inc. $MRK Bought by Talon Private Wealth LLC

Smith Chas P & Associates PA Cpas Has $46.21 Million Stake in Merck & Co., Inc. $MRK - Daily Political

MRK Banks on Growing Pipeline & New Drugs to Offset Keytruda LOE

The Manufacturers Life Insurance Company Has $266.40 Million Position in Merck & Co., Inc. $MRK

Merck & Co., Inc. (NYSE:MRK) Given Consensus Rating of "Moderate Buy" by Brokerages

IPG Investment Advisors LLC Lowers Position in Merck & Co., Inc. $MRK

Merck & Co., Inc. $MRK Shares Sold by Corient Private Wealth LP

Rep. Maria Elvira Salazar Buys Merck & Co., Inc. (NYSE:MRK) Stock

RBC Capital Sticks to Its Buy Rating for Johnson & Johnson (JNJ)

RBC Capital Reaffirms Their Hold Rating on Bristol-Myers Squibb (BMY)

Merck & Co., Inc. (NYSE:MRK) Trading Down 1.9% - Should You Sell?

MSD opens 2.5 lakh sqft technology centre in Hyderabad

MRK Maintained by HSBC -- Price Target Raised to $172

HSBC Issues Positive Forecast for Merck & Co., Inc. (NYSE:MRK) Stock Price - Stock Observer

Integrated Wealth Concepts LLC Acquires 13,850 Shares of Merck & Co., Inc. $MRK

Archford Capital Strategies LLC Has $3.52 Million Position in Merck & Co., Inc. $MRK

MRK Maintains Outperform Rating by Leerink Partners -- Price Tar

Merck & Co., Inc. (NYSE:MRK) Given New $161.00 Price Target at Leerink Partners

The Zacks Analyst Blog Highlights Oracle, Merck, Union Pacific, CVD Equipment and Koil Energy Solutions

Merck & Co., Inc. (NYSE:MRK) Price Target Raised to $161.00 - Stock Observer

Pyxis Oncology Announces Positive Updated Data from Phase 1 Monotherapy Study of Micvotabart Pelidotin (MICVO) in Second-Line and Beyond Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma...

NewEdge Advisors LLC Purchases 41,950 Shares of Merck & Co., Inc. $MRK

Merck & Co., Inc. $MRK Shares Purchased by Ameritas Advisory Services LLC

Bank of America Securities Keeps Their Buy Rating on Ionis Pharmaceuticals (IONS)

NewEdge Advisors LLC Acquires 41,950 Shares of Merck & Co., Inc. $MRK - Daily Political

RBC Capital downgrades Novartis AG (NOVN) to a Hold

RBC Capital downgrades GlaxoSmithKline (GSK) to a Hold

RBC Capital Reaffirms Their Buy Rating on AstraZeneca (AZN)

Top Stock Reports for Oracle, Merck & Union Pacific

Allworth Financial LP Decreases Holdings in Merck & Co., Inc. $MRK

RBC Capital Initiates a Hold Rating on Sanofi (SNYNF)

Merck & Co., Inc. (NYSE:MRK) Stock Price Expected to Rise, Guggenheim Analyst Says

Assessment of the Pulmonary Arterial Hypertension (PAH) Market 2026-2036 Featuring United Therapeutics, Mochida Pharmaceutical, Johnson & Johnson, Merck, and Gossamer Bio

Merck & Co., Inc. $MRK Shares Bought by Groupe la Francaise

HighTower Advisors LLC Grows Stock Holdings in Merck & Co., Inc. $MRK

VIRGINIA RETIREMENT SYSTEMS ET Al Invests $79.56 Million in Merck & Co., Inc. $MRK - Daily Political

Rose Capital Advisors LLC Purchases Shares of 4,482 Merck & Co., Inc. $MRK

NBH Bank Takes Position in Merck & Co., Inc. $MRK

Old Mission Investment Co LLC Makes New $1.34 Million Investment in Merck & Co., Inc. $MRK

Oakmont Investment Advisors Inc. Invests $3.10 Million in Merck & Co., Inc. $MRK

Three Seasons Wealth LLC Raises Stake in Merck & Co., Inc. $MRK

Maloon Powers Pitre Higgins & Dennehy LLC Invests $882,000 in Merck & Co., Inc. $MRK

Three Seasons Wealth LLC Increases Stock Position in Merck & Co., Inc. $MRK - Stock Observer

Merck (MRK) Sees a More Significant Dip Than Broader Market: Some Facts to Know

MRK Maintained by Wells Fargo -- Price Target Raised to $170

Merck & Co., Inc. (NYSE:MRK) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says

USD/CAD Forecast 2026–2030: Can Fed–BoC Rate Divergence Push the Pair Above 1.42?

Micron vs SanDisk: Which Stock Is Better Positioned for AI Growth?

AMD vs Intel vs Arm: Which Stock Could Benefit Most From the AI Inference Boom?

AMD Joins the $1 Trillion Club as AI Demand Lifts Shares: AI Chip Stock Forecast and Outlook

British Pound Short-Term Outlook: Can GBP/USD Hold 1.33 as Fed–BoE Policy Divergence Widens?

Is SpaceX a Good Stock to Buy in 2026?

Best Gold Stock to Buy Now: 6 Gold Stocks to Watch in 2026

Advanced CFD Trading Tools Review: Which Tools Can Improve Your Trading Decisions?

Gold Price Trend 2024-2026: From $2,000 to Record Highs, What Comes Next?

Upcoming IPOs 2026: The Biggest Companies to Watch and Major Listings So Far

Micron Earnings Preview: Can AI Memory Demand Lift Q4 Results Above High Expectations?

Gold Price Today: Spot Gold Slides Toward $4,200 as Fed Rate Outlook Weighs

Oil Price Today: Brent Rises Above $105 as US–Iran Talks Stall

TSMC Stock: 2nm Order Reports Put Capacity and Margins in Focus

Gold Price Today: Gold Holds Near $4,280 After Strong US PMI Sends Treasury Yields Higher

McDonald’s Stock Falls Nearly 5% as NEXT Investor Day Raises Turnaround Questions

Oil Price Today Rises Above $101 as Iran Tensions and Tanker Shortage Revive Supply Fears

USD/JPY Climbs Above 158 as US Yield Surge Revives the Risk of Intervention Near 160